nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Irinotecan—colon cancer	0.591	1	CbGbCtD
Raltegravir—CCR1—lymphoid tissue—colon cancer	0.013	0.159	CbGeAlD
Raltegravir—CCR1—digestive system—colon cancer	0.0128	0.157	CbGeAlD
Raltegravir—CCR1—bone marrow—colon cancer	0.0118	0.145	CbGeAlD
Raltegravir—CCR1—vagina—colon cancer	0.0113	0.139	CbGeAlD
Raltegravir—CCR1—liver—colon cancer	0.00957	0.117	CbGeAlD
Raltegravir—CCR1—lymph node—colon cancer	0.00733	0.0899	CbGeAlD
Raltegravir—UGT1A1—renal system—colon cancer	0.00644	0.0789	CbGeAlD
Raltegravir—UGT1A1—digestive system—colon cancer	0.00528	0.0647	CbGeAlD
Raltegravir—UGT1A1—liver—colon cancer	0.00393	0.0482	CbGeAlD
Raltegravir—Agitation—Vincristine—colon cancer	0.000698	0.00213	CcSEcCtD
Raltegravir—Ill-defined disorder—Irinotecan—colon cancer	0.000686	0.00209	CcSEcCtD
Raltegravir—Anaemia—Irinotecan—colon cancer	0.000684	0.00209	CcSEcCtD
Raltegravir—Bronchitis—Capecitabine—colon cancer	0.000683	0.00208	CcSEcCtD
Raltegravir—Vertigo—Vincristine—colon cancer	0.000682	0.00208	CcSEcCtD
Raltegravir—Abdominal discomfort—Capecitabine—colon cancer	0.000681	0.00208	CcSEcCtD
Raltegravir—Hepatic failure—Methotrexate—colon cancer	0.000681	0.00208	CcSEcCtD
Raltegravir—Malaise—Irinotecan—colon cancer	0.000667	0.00204	CcSEcCtD
Raltegravir—Vertigo—Irinotecan—colon cancer	0.000665	0.00203	CcSEcCtD
Raltegravir—Neutropenia—Capecitabine—colon cancer	0.000664	0.00203	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Capecitabine—colon cancer	0.00066	0.00201	CcSEcCtD
Raltegravir—Hypertension—Vincristine—colon cancer	0.000656	0.002	CcSEcCtD
Raltegravir—Anaemia—Fluorouracil—colon cancer	0.000655	0.002	CcSEcCtD
Raltegravir—Myalgia—Vincristine—colon cancer	0.000647	0.00197	CcSEcCtD
Raltegravir—Weight increased—Capecitabine—colon cancer	0.000647	0.00197	CcSEcCtD
Raltegravir—Cough—Irinotecan—colon cancer	0.000645	0.00197	CcSEcCtD
Raltegravir—Weight decreased—Capecitabine—colon cancer	0.000643	0.00196	CcSEcCtD
Raltegravir—Hyperglycaemia—Capecitabine—colon cancer	0.000641	0.00196	CcSEcCtD
Raltegravir—Hypertension—Irinotecan—colon cancer	0.000639	0.00195	CcSEcCtD
Raltegravir—Infestation NOS—Capecitabine—colon cancer	0.000634	0.00193	CcSEcCtD
Raltegravir—Infestation—Capecitabine—colon cancer	0.000634	0.00193	CcSEcCtD
Raltegravir—Depression—Capecitabine—colon cancer	0.000632	0.00193	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000628	0.00192	CcSEcCtD
Raltegravir—Acute coronary syndrome—Capecitabine—colon cancer	0.000625	0.00191	CcSEcCtD
Raltegravir—Lethargy—Methotrexate—colon cancer	0.000624	0.00191	CcSEcCtD
Raltegravir—Renal failure—Capecitabine—colon cancer	0.000623	0.0019	CcSEcCtD
Raltegravir—Discomfort—Irinotecan—colon cancer	0.000622	0.0019	CcSEcCtD
Raltegravir—Myocardial infarction—Capecitabine—colon cancer	0.000621	0.00189	CcSEcCtD
Raltegravir—Neuropathy peripheral—Capecitabine—colon cancer	0.000621	0.00189	CcSEcCtD
Raltegravir—Infection—Vincristine—colon cancer	0.000616	0.00188	CcSEcCtD
Raltegravir—Confusional state—Irinotecan—colon cancer	0.000609	0.00186	CcSEcCtD
Raltegravir—Nervous system disorder—Vincristine—colon cancer	0.000608	0.00185	CcSEcCtD
Raltegravir—Thrombocytopenia—Vincristine—colon cancer	0.000607	0.00185	CcSEcCtD
Raltegravir—Haematuria—Capecitabine—colon cancer	0.000604	0.00184	CcSEcCtD
Raltegravir—Chest pain—Fluorouracil—colon cancer	0.000603	0.00184	CcSEcCtD
Raltegravir—Myalgia—Fluorouracil—colon cancer	0.000603	0.00184	CcSEcCtD
Raltegravir—Infection—Irinotecan—colon cancer	0.0006	0.00183	CcSEcCtD
Raltegravir—Hyperhidrosis—Vincristine—colon cancer	0.000599	0.00183	CcSEcCtD
Raltegravir—Hepatobiliary disease—Capecitabine—colon cancer	0.000599	0.00183	CcSEcCtD
Raltegravir—Epistaxis—Capecitabine—colon cancer	0.000598	0.00182	CcSEcCtD
Raltegravir—Discomfort—Fluorouracil—colon cancer	0.000596	0.00182	CcSEcCtD
Raltegravir—Nervous system disorder—Irinotecan—colon cancer	0.000592	0.00181	CcSEcCtD
Raltegravir—Thrombocytopenia—Irinotecan—colon cancer	0.000591	0.0018	CcSEcCtD
Raltegravir—Hyperhidrosis—Irinotecan—colon cancer	0.000584	0.00178	CcSEcCtD
Raltegravir—Confusional state—Fluorouracil—colon cancer	0.000583	0.00178	CcSEcCtD
Raltegravir—Mood swings—Methotrexate—colon cancer	0.00058	0.00177	CcSEcCtD
Raltegravir—Infection—Fluorouracil—colon cancer	0.000574	0.00175	CcSEcCtD
Raltegravir—Hepatitis—Capecitabine—colon cancer	0.000569	0.00174	CcSEcCtD
Raltegravir—Nervous system disorder—Fluorouracil—colon cancer	0.000567	0.00173	CcSEcCtD
Raltegravir—Thrombocytopenia—Fluorouracil—colon cancer	0.000566	0.00173	CcSEcCtD
Raltegravir—Hypoaesthesia—Capecitabine—colon cancer	0.000566	0.00173	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Vincristine—colon cancer	0.000565	0.00172	CcSEcCtD
Raltegravir—Urinary tract disorder—Capecitabine—colon cancer	0.000562	0.00171	CcSEcCtD
Raltegravir—Insomnia—Vincristine—colon cancer	0.000561	0.00171	CcSEcCtD
Raltegravir—Oedema peripheral—Capecitabine—colon cancer	0.00056	0.00171	CcSEcCtD
Raltegravir—Connective tissue disorder—Capecitabine—colon cancer	0.000559	0.0017	CcSEcCtD
Raltegravir—Urethral disorder—Capecitabine—colon cancer	0.000557	0.0017	CcSEcCtD
Raltegravir—Paraesthesia—Vincristine—colon cancer	0.000557	0.0017	CcSEcCtD
Raltegravir—Breast disorder—Methotrexate—colon cancer	0.000553	0.00169	CcSEcCtD
Raltegravir—Visual impairment—Capecitabine—colon cancer	0.000548	0.00167	CcSEcCtD
Raltegravir—Insomnia—Irinotecan—colon cancer	0.000546	0.00167	CcSEcCtD
Raltegravir—Paraesthesia—Irinotecan—colon cancer	0.000542	0.00165	CcSEcCtD
Raltegravir—Decreased appetite—Vincristine—colon cancer	0.000539	0.00164	CcSEcCtD
Raltegravir—Erythema multiforme—Capecitabine—colon cancer	0.000538	0.00164	CcSEcCtD
Raltegravir—Somnolence—Irinotecan—colon cancer	0.000537	0.00164	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Vincristine—colon cancer	0.000535	0.00163	CcSEcCtD
Raltegravir—Fatigue—Vincristine—colon cancer	0.000534	0.00163	CcSEcCtD
Raltegravir—Eye disorder—Capecitabine—colon cancer	0.000531	0.00162	CcSEcCtD
Raltegravir—Dyspepsia—Irinotecan—colon cancer	0.000531	0.00162	CcSEcCtD
Raltegravir—Tinnitus—Capecitabine—colon cancer	0.00053	0.00162	CcSEcCtD
Raltegravir—Pain—Vincristine—colon cancer	0.00053	0.00162	CcSEcCtD
Raltegravir—Constipation—Vincristine—colon cancer	0.00053	0.00162	CcSEcCtD
Raltegravir—Cardiac disorder—Capecitabine—colon cancer	0.000528	0.00161	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000527	0.00161	CcSEcCtD
Raltegravir—Decreased appetite—Irinotecan—colon cancer	0.000525	0.0016	CcSEcCtD
Raltegravir—Eosinophilia—Methotrexate—colon cancer	0.000524	0.0016	CcSEcCtD
Raltegravir—Insomnia—Fluorouracil—colon cancer	0.000523	0.0016	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000521	0.00159	CcSEcCtD
Raltegravir—Fatigue—Irinotecan—colon cancer	0.00052	0.00159	CcSEcCtD
Raltegravir—Paraesthesia—Fluorouracil—colon cancer	0.000519	0.00158	CcSEcCtD
Raltegravir—Pain—Irinotecan—colon cancer	0.000516	0.00157	CcSEcCtD
Raltegravir—Constipation—Irinotecan—colon cancer	0.000516	0.00157	CcSEcCtD
Raltegravir—Angiopathy—Capecitabine—colon cancer	0.000516	0.00157	CcSEcCtD
Raltegravir—Somnolence—Fluorouracil—colon cancer	0.000514	0.00157	CcSEcCtD
Raltegravir—Immune system disorder—Capecitabine—colon cancer	0.000514	0.00157	CcSEcCtD
Raltegravir—Mediastinal disorder—Capecitabine—colon cancer	0.000513	0.00156	CcSEcCtD
Raltegravir—Chills—Capecitabine—colon cancer	0.00051	0.00156	CcSEcCtD
Raltegravir—Dyspepsia—Fluorouracil—colon cancer	0.000509	0.00155	CcSEcCtD
Raltegravir—Abdominal discomfort—Methotrexate—colon cancer	0.000507	0.00155	CcSEcCtD
Raltegravir—Gastrointestinal pain—Vincristine—colon cancer	0.000507	0.00155	CcSEcCtD
Raltegravir—Decreased appetite—Fluorouracil—colon cancer	0.000503	0.00153	CcSEcCtD
Raltegravir—Alopecia—Capecitabine—colon cancer	0.000503	0.00153	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000499	0.00152	CcSEcCtD
Raltegravir—Mental disorder—Capecitabine—colon cancer	0.000498	0.00152	CcSEcCtD
Raltegravir—Feeling abnormal—Irinotecan—colon cancer	0.000497	0.00152	CcSEcCtD
Raltegravir—Erythema—Capecitabine—colon cancer	0.000495	0.00151	CcSEcCtD
Raltegravir—Malnutrition—Capecitabine—colon cancer	0.000495	0.00151	CcSEcCtD
Raltegravir—Neutropenia—Methotrexate—colon cancer	0.000495	0.00151	CcSEcCtD
Raltegravir—Pain—Fluorouracil—colon cancer	0.000494	0.00151	CcSEcCtD
Raltegravir—Gastrointestinal pain—Irinotecan—colon cancer	0.000494	0.00151	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Methotrexate—colon cancer	0.000492	0.0015	CcSEcCtD
Raltegravir—Body temperature increased—Vincristine—colon cancer	0.00049	0.0015	CcSEcCtD
Raltegravir—Abdominal pain—Vincristine—colon cancer	0.00049	0.0015	CcSEcCtD
Raltegravir—Flatulence—Capecitabine—colon cancer	0.000488	0.00149	CcSEcCtD
Raltegravir—Erectile dysfunction—Methotrexate—colon cancer	0.000487	0.00149	CcSEcCtD
Raltegravir—Dysgeusia—Capecitabine—colon cancer	0.000485	0.00148	CcSEcCtD
Raltegravir—Back pain—Capecitabine—colon cancer	0.000479	0.00146	CcSEcCtD
Raltegravir—Abdominal pain—Irinotecan—colon cancer	0.000477	0.00146	CcSEcCtD
Raltegravir—Body temperature increased—Irinotecan—colon cancer	0.000477	0.00146	CcSEcCtD
Raltegravir—Feeling abnormal—Fluorouracil—colon cancer	0.000476	0.00145	CcSEcCtD
Raltegravir—Infestation NOS—Methotrexate—colon cancer	0.000472	0.00144	CcSEcCtD
Raltegravir—Infestation—Methotrexate—colon cancer	0.000472	0.00144	CcSEcCtD
Raltegravir—Depression—Methotrexate—colon cancer	0.00047	0.00143	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000468	0.00143	CcSEcCtD
Raltegravir—Tremor—Capecitabine—colon cancer	0.000464	0.00142	CcSEcCtD
Raltegravir—Renal failure—Methotrexate—colon cancer	0.000464	0.00141	CcSEcCtD
Raltegravir—Ill-defined disorder—Capecitabine—colon cancer	0.000459	0.0014	CcSEcCtD
Raltegravir—Urticaria—Fluorouracil—colon cancer	0.000459	0.0014	CcSEcCtD
Raltegravir—Anaemia—Capecitabine—colon cancer	0.000458	0.0014	CcSEcCtD
Raltegravir—Body temperature increased—Fluorouracil—colon cancer	0.000457	0.00139	CcSEcCtD
Raltegravir—Hypersensitivity—Vincristine—colon cancer	0.000457	0.00139	CcSEcCtD
Raltegravir—Haematuria—Methotrexate—colon cancer	0.00045	0.00137	CcSEcCtD
Raltegravir—Malaise—Capecitabine—colon cancer	0.000446	0.00136	CcSEcCtD
Raltegravir—Hepatobiliary disease—Methotrexate—colon cancer	0.000446	0.00136	CcSEcCtD
Raltegravir—Epistaxis—Methotrexate—colon cancer	0.000445	0.00136	CcSEcCtD
Raltegravir—Vertigo—Capecitabine—colon cancer	0.000445	0.00136	CcSEcCtD
Raltegravir—Hypersensitivity—Irinotecan—colon cancer	0.000445	0.00136	CcSEcCtD
Raltegravir—Asthenia—Vincristine—colon cancer	0.000445	0.00136	CcSEcCtD
Raltegravir—Palpitations—Capecitabine—colon cancer	0.000437	0.00133	CcSEcCtD
Raltegravir—Asthenia—Irinotecan—colon cancer	0.000433	0.00132	CcSEcCtD
Raltegravir—Cough—Capecitabine—colon cancer	0.000432	0.00132	CcSEcCtD
Raltegravir—Hypertension—Capecitabine—colon cancer	0.000427	0.0013	CcSEcCtD
Raltegravir—Hypersensitivity—Fluorouracil—colon cancer	0.000426	0.0013	CcSEcCtD
Raltegravir—Diarrhoea—Vincristine—colon cancer	0.000424	0.00129	CcSEcCtD
Raltegravir—Hepatitis—Methotrexate—colon cancer	0.000423	0.00129	CcSEcCtD
Raltegravir—Arthralgia—Capecitabine—colon cancer	0.000421	0.00129	CcSEcCtD
Raltegravir—Chest pain—Capecitabine—colon cancer	0.000421	0.00129	CcSEcCtD
Raltegravir—Myalgia—Capecitabine—colon cancer	0.000421	0.00129	CcSEcCtD
Raltegravir—Anxiety—Capecitabine—colon cancer	0.00042	0.00128	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000419	0.00128	CcSEcCtD
Raltegravir—Urinary tract disorder—Methotrexate—colon cancer	0.000418	0.00128	CcSEcCtD
Raltegravir—Discomfort—Capecitabine—colon cancer	0.000416	0.00127	CcSEcCtD
Raltegravir—Urethral disorder—Methotrexate—colon cancer	0.000415	0.00127	CcSEcCtD
Raltegravir—Diarrhoea—Irinotecan—colon cancer	0.000413	0.00126	CcSEcCtD
Raltegravir—Dry mouth—Capecitabine—colon cancer	0.000412	0.00126	CcSEcCtD
Raltegravir—Dizziness—Vincristine—colon cancer	0.00041	0.00125	CcSEcCtD
Raltegravir—Pruritus—Fluorouracil—colon cancer	0.000409	0.00125	CcSEcCtD
Raltegravir—Visual impairment—Methotrexate—colon cancer	0.000408	0.00124	CcSEcCtD
Raltegravir—Confusional state—Capecitabine—colon cancer	0.000407	0.00124	CcSEcCtD
Raltegravir—Infection—Capecitabine—colon cancer	0.000401	0.00122	CcSEcCtD
Raltegravir—Erythema multiforme—Methotrexate—colon cancer	0.0004	0.00122	CcSEcCtD
Raltegravir—Dizziness—Irinotecan—colon cancer	0.000399	0.00122	CcSEcCtD
Raltegravir—Nervous system disorder—Capecitabine—colon cancer	0.000396	0.00121	CcSEcCtD
Raltegravir—Eye disorder—Methotrexate—colon cancer	0.000396	0.00121	CcSEcCtD
Raltegravir—Diarrhoea—Fluorouracil—colon cancer	0.000396	0.00121	CcSEcCtD
Raltegravir—Thrombocytopenia—Capecitabine—colon cancer	0.000396	0.00121	CcSEcCtD
Raltegravir—Tinnitus—Methotrexate—colon cancer	0.000395	0.0012	CcSEcCtD
Raltegravir—Vomiting—Vincristine—colon cancer	0.000394	0.0012	CcSEcCtD
Raltegravir—Cardiac disorder—Methotrexate—colon cancer	0.000393	0.0012	CcSEcCtD
Raltegravir—Skin disorder—Capecitabine—colon cancer	0.000392	0.0012	CcSEcCtD
Raltegravir—Rash—Vincristine—colon cancer	0.000391	0.00119	CcSEcCtD
Raltegravir—Hyperhidrosis—Capecitabine—colon cancer	0.000391	0.00119	CcSEcCtD
Raltegravir—Dermatitis—Vincristine—colon cancer	0.00039	0.00119	CcSEcCtD
Raltegravir—Headache—Vincristine—colon cancer	0.000388	0.00118	CcSEcCtD
Raltegravir—Angiopathy—Methotrexate—colon cancer	0.000384	0.00117	CcSEcCtD
Raltegravir—Vomiting—Irinotecan—colon cancer	0.000384	0.00117	CcSEcCtD
Raltegravir—Immune system disorder—Methotrexate—colon cancer	0.000382	0.00117	CcSEcCtD
Raltegravir—Dizziness—Fluorouracil—colon cancer	0.000382	0.00117	CcSEcCtD
Raltegravir—Mediastinal disorder—Methotrexate—colon cancer	0.000382	0.00116	CcSEcCtD
Raltegravir—Rash—Irinotecan—colon cancer	0.000381	0.00116	CcSEcCtD
Raltegravir—Dermatitis—Irinotecan—colon cancer	0.00038	0.00116	CcSEcCtD
Raltegravir—Chills—Methotrexate—colon cancer	0.00038	0.00116	CcSEcCtD
Raltegravir—Headache—Irinotecan—colon cancer	0.000378	0.00115	CcSEcCtD
Raltegravir—Alopecia—Methotrexate—colon cancer	0.000374	0.00114	CcSEcCtD
Raltegravir—Mental disorder—Methotrexate—colon cancer	0.000371	0.00113	CcSEcCtD
Raltegravir—Malnutrition—Methotrexate—colon cancer	0.000369	0.00112	CcSEcCtD
Raltegravir—Erythema—Methotrexate—colon cancer	0.000369	0.00112	CcSEcCtD
Raltegravir—Nausea—Vincristine—colon cancer	0.000368	0.00112	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000368	0.00112	CcSEcCtD
Raltegravir—Vomiting—Fluorouracil—colon cancer	0.000368	0.00112	CcSEcCtD
Raltegravir—Insomnia—Capecitabine—colon cancer	0.000365	0.00111	CcSEcCtD
Raltegravir—Rash—Fluorouracil—colon cancer	0.000365	0.00111	CcSEcCtD
Raltegravir—Dermatitis—Fluorouracil—colon cancer	0.000364	0.00111	CcSEcCtD
Raltegravir—Paraesthesia—Capecitabine—colon cancer	0.000363	0.00111	CcSEcCtD
Raltegravir—Headache—Fluorouracil—colon cancer	0.000362	0.00111	CcSEcCtD
Raltegravir—Dysgeusia—Methotrexate—colon cancer	0.000361	0.0011	CcSEcCtD
Raltegravir—Nausea—Irinotecan—colon cancer	0.000359	0.00109	CcSEcCtD
Raltegravir—Back pain—Methotrexate—colon cancer	0.000356	0.00109	CcSEcCtD
Raltegravir—Dyspepsia—Capecitabine—colon cancer	0.000356	0.00109	CcSEcCtD
Raltegravir—Decreased appetite—Capecitabine—colon cancer	0.000351	0.00107	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000349	0.00106	CcSEcCtD
Raltegravir—Fatigue—Capecitabine—colon cancer	0.000348	0.00106	CcSEcCtD
Raltegravir—Constipation—Capecitabine—colon cancer	0.000346	0.00105	CcSEcCtD
Raltegravir—Pain—Capecitabine—colon cancer	0.000346	0.00105	CcSEcCtD
Raltegravir—Nausea—Fluorouracil—colon cancer	0.000343	0.00105	CcSEcCtD
Raltegravir—Ill-defined disorder—Methotrexate—colon cancer	0.000342	0.00104	CcSEcCtD
Raltegravir—Anaemia—Methotrexate—colon cancer	0.000341	0.00104	CcSEcCtD
Raltegravir—Feeling abnormal—Capecitabine—colon cancer	0.000333	0.00102	CcSEcCtD
Raltegravir—Malaise—Methotrexate—colon cancer	0.000332	0.00101	CcSEcCtD
Raltegravir—Vertigo—Methotrexate—colon cancer	0.000331	0.00101	CcSEcCtD
Raltegravir—Gastrointestinal pain—Capecitabine—colon cancer	0.00033	0.00101	CcSEcCtD
Raltegravir—Cough—Methotrexate—colon cancer	0.000322	0.000981	CcSEcCtD
Raltegravir—Urticaria—Capecitabine—colon cancer	0.000321	0.000979	CcSEcCtD
Raltegravir—Abdominal pain—Capecitabine—colon cancer	0.000319	0.000974	CcSEcCtD
Raltegravir—Body temperature increased—Capecitabine—colon cancer	0.000319	0.000974	CcSEcCtD
Raltegravir—Arthralgia—Methotrexate—colon cancer	0.000314	0.000957	CcSEcCtD
Raltegravir—Chest pain—Methotrexate—colon cancer	0.000314	0.000957	CcSEcCtD
Raltegravir—Myalgia—Methotrexate—colon cancer	0.000314	0.000957	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000312	0.000951	CcSEcCtD
Raltegravir—Discomfort—Methotrexate—colon cancer	0.00031	0.000946	CcSEcCtD
Raltegravir—Confusional state—Methotrexate—colon cancer	0.000303	0.000925	CcSEcCtD
Raltegravir—Infection—Methotrexate—colon cancer	0.000299	0.000912	CcSEcCtD
Raltegravir—Hypersensitivity—Capecitabine—colon cancer	0.000298	0.000908	CcSEcCtD
Raltegravir—Nervous system disorder—Methotrexate—colon cancer	0.000295	0.0009	CcSEcCtD
Raltegravir—Thrombocytopenia—Methotrexate—colon cancer	0.000294	0.000898	CcSEcCtD
Raltegravir—Skin disorder—Methotrexate—colon cancer	0.000292	0.000891	CcSEcCtD
Raltegravir—Hyperhidrosis—Methotrexate—colon cancer	0.000291	0.000887	CcSEcCtD
Raltegravir—Asthenia—Capecitabine—colon cancer	0.00029	0.000884	CcSEcCtD
Raltegravir—Pruritus—Capecitabine—colon cancer	0.000286	0.000872	CcSEcCtD
Raltegravir—Diarrhoea—Capecitabine—colon cancer	0.000276	0.000843	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000274	0.000836	CcSEcCtD
Raltegravir—Insomnia—Methotrexate—colon cancer	0.000272	0.00083	CcSEcCtD
Raltegravir—Paraesthesia—Methotrexate—colon cancer	0.00027	0.000824	CcSEcCtD
Raltegravir—Somnolence—Methotrexate—colon cancer	0.000267	0.000816	CcSEcCtD
Raltegravir—Dizziness—Capecitabine—colon cancer	0.000267	0.000815	CcSEcCtD
Raltegravir—Dyspepsia—Methotrexate—colon cancer	0.000265	0.000808	CcSEcCtD
Raltegravir—Decreased appetite—Methotrexate—colon cancer	0.000261	0.000798	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Methotrexate—colon cancer	0.00026	0.000792	CcSEcCtD
Raltegravir—Fatigue—Methotrexate—colon cancer	0.000259	0.000791	CcSEcCtD
Raltegravir—Pain—Methotrexate—colon cancer	0.000257	0.000785	CcSEcCtD
Raltegravir—Vomiting—Capecitabine—colon cancer	0.000257	0.000784	CcSEcCtD
Raltegravir—Rash—Capecitabine—colon cancer	0.000255	0.000777	CcSEcCtD
Raltegravir—Dermatitis—Capecitabine—colon cancer	0.000255	0.000777	CcSEcCtD
Raltegravir—Headache—Capecitabine—colon cancer	0.000253	0.000772	CcSEcCtD
Raltegravir—Feeling abnormal—Methotrexate—colon cancer	0.000248	0.000756	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methotrexate—colon cancer	0.000246	0.00075	CcSEcCtD
Raltegravir—Nausea—Capecitabine—colon cancer	0.00024	0.000732	CcSEcCtD
Raltegravir—Urticaria—Methotrexate—colon cancer	0.000239	0.000729	CcSEcCtD
Raltegravir—Body temperature increased—Methotrexate—colon cancer	0.000238	0.000725	CcSEcCtD
Raltegravir—Abdominal pain—Methotrexate—colon cancer	0.000238	0.000725	CcSEcCtD
Raltegravir—Hypersensitivity—Methotrexate—colon cancer	0.000222	0.000676	CcSEcCtD
Raltegravir—Asthenia—Methotrexate—colon cancer	0.000216	0.000658	CcSEcCtD
Raltegravir—Pruritus—Methotrexate—colon cancer	0.000213	0.000649	CcSEcCtD
Raltegravir—Diarrhoea—Methotrexate—colon cancer	0.000206	0.000628	CcSEcCtD
Raltegravir—Dizziness—Methotrexate—colon cancer	0.000199	0.000607	CcSEcCtD
Raltegravir—Vomiting—Methotrexate—colon cancer	0.000191	0.000583	CcSEcCtD
Raltegravir—Rash—Methotrexate—colon cancer	0.00019	0.000579	CcSEcCtD
Raltegravir—Dermatitis—Methotrexate—colon cancer	0.000189	0.000578	CcSEcCtD
Raltegravir—Headache—Methotrexate—colon cancer	0.000188	0.000575	CcSEcCtD
Raltegravir—Nausea—Methotrexate—colon cancer	0.000179	0.000545	CcSEcCtD
